Bristol Myers Squibb (BMY) Operating Income Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) Operating Income Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 10.16%
Dec 31, 2025 27.77%
Sep 30, 2025 -5.55%
Jun 30, 2025 -8.33%
Mar 31, 2025 56.47%
Dec 31, 2024 -12.09%
Sep 30, 2024 -23.77%
Jun 30, 2024 -58.83%
Mar 31, 2024 -148.74%
Dec 31, 2023 -59.12%
Sep 30, 2023 -22.07%
Jun 30, 2023 1.70%
Mar 31, 2023 0.91%
Dec 31, 2022 4.06%
Sep 30, 2022 18.32%
Jun 30, 2022 -22.70%
Mar 31, 2022 -25.68%
Dec 31, 2021 -9.25%
Sep 30, 2021 -20.38%
Jun 30, 2021 -33.23%